SEC 13F Intelligence

Ghost Tree Capital, LLC / FPRX

Ghost Tree Capital, LLC’s Five Prime Therapeutics Inc Position

Does Ghost Tree Capital, LLC own Five Prime Therapeutics Inc (FPRX)? Not currently — the last reported position was 500.0K shares worth $9M in Q4 2020; the fund’s latest 13F (Q3 2024) no longer reports it.

Position Value
$9M
Q4 2020
Shares
500.0K
% of Portfolio
+1.90%
Quarters Held
1
position exited

Position History FPRX

Reported value by quarter
Q4 ’20: $9MQ4 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2020500.0K$9M+1.90%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ghost Tree Capital, LLC’s full portfolio or all institutional holders of FPRX.